Economic Consequences of Diabetes Mellitus in the U.S. in 1997

Abstract

The economic burden of diabetes mellitus in the U.S. is enormous. Medical innovations that can delay the onset and slow the progression of diabetes have tremendous potential to mitigate the associated clinical and cost repercussions.